Analyst 2
IntegriChain
Analyst 2
IntegriChain
Life sciences data analytics for access
Your mission at IntegriChain:
Gross-to-Net is the gap between a drug’s list price and the net revenue a manufacturer realizes after rebates, chargebacks, discounts, and fees. Grss-to-Net is central to how pharmaceutical companies forecast, report, and plan.
As a GTN Analyst II, you will support multiple external clients by reconciling transactional data, validating pricing calculations, explaining variances, and producing the reports they rely on to meet contractual deadlines. You will work across our GTN systems and Excel, partner with colleagues in Pune and remote teams in the U.S. and build expertise in pharmaceutical revenue management.
Working hours: This is a hybrid role based in Pune. Because you will work closely with U.S.-based clients and managers, the role requires some overlap with U.S. Eastern working hours
What you’ll do to thrive in this role:
Where You’ll Grow:
What you’ll bring to the table:
Nice to have
What does IntegriChain have to offer?
#LI-YG1
IntegriChain is committed to equal treatment and opportunity in all aspects of recruitment, selection, and employment without regard to race, color, religion, national origin, ethnicity, age, sex, marital status, physical or mental disability, gender identity, sexual orientation, veteran or military status, or any other category protected under the law. IntegriChain is an equal opportunity employer; committed to creating a community of inclusion, and an environment free from discrimination, harassment, and retaliation.
Life sciences data analytics for access
IntegriChain provides data-driven analytics for the life sciences industry to improve patient access to therapies. It combines an subscription-based data platform with managed services to cover the full brand lifecycle, from pre-launch to post-market. Its platform collects and aggregates data and applies analytics to identify access obstacles and opportunities in areas like government pricing, rebates, and gross-to-net calculations, helping pharmaceutical manufacturers optimize distribution and pricing strategies. The company differentiates itself by offering an end-to-end solution that blends technology with hands-on managed services, serving a broad base of clients (more than 220 life sciences companies) and using private equity backing to expand capabilities. Its goal is to help clients remove access barriers and maximize patient access to therapies while improving commercial operations.
Explore more opportunities at IntegriChain